References
- Bearden WO, Mason JB. Consumer-perceived risk and attitudes toward generically prescribed drugs. J Appl Psychol 1978;63:741–6.
- Bellizzi IS, Krueckeberg 11F, Hamilton JR, Martin WS. Consumer percep-tions of national, private, and generic brands. J Retail 1981;57(4):56–70.
- Cunningham IC, Hardy AP, 1mperia G. Generic brands versus national brands and store brands. 1 Advertis Res 1982;22(Fall):25–32.
- Granzin ILL. An investigation of the marketing for generic products. S Re-tail 1981;57(4):39–55.
- Lambert ZV, Doering PL, Goldstein E, McCormick WC. Predispositions toward generic drug acceptance. J Consumer Res 1980;7:14–23.
- Schumer RM. People's choice: Part I, Consumer influence in drug sub-stitution. Pharm Exec 1987;(Nov):54–8.
- Mason BJ, Bearden WO. Generic drugs: consumer, pharmacist, and physi-cian perceptions of the issues.1 Consumer Affairs 1980;14(Surnmer):193–206.
- Palo CP. The framing of buying decisions. I Consumer Res 1987;14:301–15.
- Bettman JR, Whan PC. Effects of prior knowledge and experience and phase of the choice process on consumer decision processes. J Consumer Res 1980;7:234–48.
- Goering P. Effects of product trial on consumer expectations, demand, and prices.1 Consumer Res 1985;12:74–82.
- Johnson El, Russo SE. Product familiarity and learning new information. J Consumer Res 1984;11:542–50.
- Johnson MD. Consumer choice strategies for comparing noncomparable alternatives. J Consumer Res 1984;11:741–53.
- Johnson MD. Comparability and hierarchical processing in multialtema-tine choice. I Consumer Res 1988;15:303–14.
- Wilke WL. Consumer behavior. New York: John Wiley and Sons, 1986.
- DuPont Pharmaceuticals, Inc. POPA1/DuPont study eyes consumer behav-ior. Chain Drug Rev 1984;(Sept 10).